- Home
- / Neptunus
Neptunus
Stock Price
$0.1
2024-10-29
Market Capitalization
$226.5 M
2024-10-29
Revenue
¥972 M
FY, 2025
Neptunus Summary
Company Summary
- Overview
- Neptunus is a biotechnology company that produces and distributes medicines. Its products include herbal medicines, transfusion and antitumor drugs, in-vitro diagnostic reagents, etc. The company offers research and development, and sales services.
- Type
- Public
- Status
- Active
- Founded
- 1989
- HQ
- Shen Zhen Shi, CN | view all locations
- Website
- http://www.interlong.com
- Cybersecurity rating
- Sectors
Table of Contents
LocationsView all
1 location detected
Shen Zhen Shi, Guang Dong Sheng HQ
China
Xiang Gang Li Gong Da Xue Chan Xue Yan Da Lou, 科技园 Nan Shan Qu
Neptunus Financials
Summary Financials
- Revenue (FY, 2025)
- ¥972.0M
- Gross profit (FY, 2025)
- ¥330.8M
- Net income (FY, 2025)
- (¥53.1M)
- Cash (FY, 2025)
- ¥199.4M
- EBIT (FY, 2025)
- (¥33.3M)
- Enterprise value
- $131.1M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026